Clinicians from Columbia and Weill Cornell Medicine are at the forefront of pulmonary medicine and lung surgery combine leading-edge therapies with compassionate care for patients with all types and stages of lung disease. Our researchers are contributing to promising advances in acute lung injury, COPD, interstitial lung disease, and pulmonary hypertension.
Pulmonology & Lung Surgery
Featured Updates
Results from a new multi-center study, led by oncologists at NewYork-Presbyterian and Weill Cornell Medicine, has described for the first time a key biomarker – absolute lymphocyte count (ALC) – that has the potential to predict therapeutic response to chimeric antigen receptor (CAR) T-cell immunotherapy for patients with relapsed/refractory multiple myeloma. While this FDA-approved treatment is widely used, until now there has not been a way to predict whether B-cell maturation antigen (BCMA) CAR T-cell therapy would elicit a good response.
The Latest
Pediatric Neurology & Neurosurgery
Crossing Specialty Lines for Rare Genetic Neurocutaneous Conditions
